Common data elements to standardize genomics studies in cerebral palsy.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
12 2022
Historique:
revised: 23 03 2022
received: 30 09 2021
accepted: 23 03 2022
pubmed: 21 4 2022
medline: 3 11 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

To define clinical common data elements (CDEs) and a mandatory minimum data set (MDS) for genomic studies of cerebral palsy (CP). Candidate data elements were collated following a review of the literature and existing CDEs. An online, three-round Delphi survey was used to rate each data element as either 'core', 'recommended', 'exploratory', or 'not required'. Members of the International Cerebral Palsy Genomics Consortium (ICPGC) rated the core CDEs as either mandatory or not, to form the MDS. For both the CDEs and the MDS, a data element was considered to have reached consensus if more than 75% of respondents agreed. Forty-six individuals from around the world formed the Delphi panel: consumers (n=2), scientists/researchers (n=17), medical (n=19), and allied health professionals (n=8). The CDEs include 107 data elements across six categories: demographics, diagnostics, family history, antenatal and neonatal details, clinical traits, and CP-specific assessments. Of these, 10 are mandatory, 42 core, 41 recommended, and 14 are exploratory. The ICPGC CDEs provide a foundation for the standardization of phenotype data captured in CP genomic studies and will benefit international collaborations and pooling of data, particularly in rare conditions. A set of 107 common data elements (CDEs) for genomics studies in cerebral palsy is provided. The CDEs include standard definitions and data values domains. The CDEs will facilitate international data sharing, collaboration, and improved clinical interpretation of findings. Definir elementos de dados clínicos comuns (DCC) e um conjunto mínimo de dados obrigatórios (CMDO) para estudos genômicos de paralisia cerebral (PC). MÉTODO: Os elementos de dados do candidato foram coletados seguindo uma revisão da literatura e através dos DCC existentes. Uma pesquisa on-line de três rodadas Delphi foi usada para classificar cada elemento de dados como 'essencial', 'recomendado', 'exploratório' ou 'não obrigatório'. Os Membros do Consorcio Internacional de Genoma na Paralisia Cerebral (MCIGPC) classificaram os DCC do núcleo como obrigatórios ou não, para formar o CMDO. Tanto para os DCC quanto para o CMDO, um elemento de dados foi considerado como tendo chegado a um consenso se mais de 75% dos respondentes concordassem. Quarenta e seis indivíduos de todo o mundo formaram o painel Delphi: consumidores (n=2), cientistas/pesquisadores (n=17), médicos (n=19) e profissionais de saúde aliados (n=8). Os DCC incluem 107 elementos de dados em seis categorias: demografia, diagnóstico, história familiar, detalhes pré-natais e neonatais, características clínicas e avaliações específicas de PC. Destes, 10 são obrigatórios, 42 essenciais, 41 recomendados e 14 são exploratórios INTERPRETAÇÃO: Os DCC do MCIGPC fornecem uma base para a padronização de dados de fenótipo capturados em estudos genômicos de PC e beneficiarão colaborações internacionais e agrupamento de dados, particularmente em condições raras.

Autres résumés

Type: Publisher (por)
Definir elementos de dados clínicos comuns (DCC) e um conjunto mínimo de dados obrigatórios (CMDO) para estudos genômicos de paralisia cerebral (PC). MÉTODO: Os elementos de dados do candidato foram coletados seguindo uma revisão da literatura e através dos DCC existentes. Uma pesquisa on-line de três rodadas Delphi foi usada para classificar cada elemento de dados como 'essencial', 'recomendado', 'exploratório' ou 'não obrigatório'. Os Membros do Consorcio Internacional de Genoma na Paralisia Cerebral (MCIGPC) classificaram os DCC do núcleo como obrigatórios ou não, para formar o CMDO. Tanto para os DCC quanto para o CMDO, um elemento de dados foi considerado como tendo chegado a um consenso se mais de 75% dos respondentes concordassem.

Identifiants

pubmed: 35441707
doi: 10.1111/dmcn.15245
pmc: PMC9790418
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1470-1476

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS106298
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.

Références

Palliat Med. 2017 Sep;31(8):684-706
pubmed: 28190381
Dev Med Child Neurol. 2017 May;59(5):462-469
pubmed: 28042670
Arch Public Health. 2014 Oct 13;72(1):35
pubmed: 25352985
Dev Med Child Neurol. 2018 Oct;60(10):976-986
pubmed: 29542813
J Biomed Inform. 2020 Jul;107:103421
pubmed: 32407878
Contemp Clin Trials. 2015 May;42:78-80
pubmed: 25797358
Clin Trials. 2012 Jun;9(3):322-9
pubmed: 22371630
Sci Transl Med. 2014 Sep 17;6(254):254fs35
pubmed: 25232173
Nucleic Acids Res. 2021 Jan 8;49(D1):D1207-D1217
pubmed: 33264411
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Dev Med Child Neurol. 2020 Jan;62(1):104-110
pubmed: 31180136
J Clin Epidemiol. 2014 Apr;67(4):401-9
pubmed: 24581294
Pediatr Crit Care Med. 2020 Nov;21(11):e1038-e1041
pubmed: 32639472
EBioMedicine. 2018 Feb;28:162-167
pubmed: 29339100
Ophthalmic Physiol Opt. 2017 Jul;37(4):428-439
pubmed: 28470770
Clin Trials. 2016 Dec;13(6):671-676
pubmed: 27311638
J Rheumatol. 2017 Dec;44(12):1813-1822
pubmed: 28966205
Dev Med Child Neurol. 2018 Feb;60(2):209-210
pubmed: 29336076
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Respirology. 2018 Oct;23(10):927-934
pubmed: 29641841
Front Public Health. 2020 Sep 22;8:457
pubmed: 33072683
Acta Obstet Gynecol Scand. 2011 Oct;90(10):1070-81
pubmed: 21682697
Dev Med Child Neurol. 2013 Jun;55(6):499-508
pubmed: 23181910
Nucleic Acids Res. 2019 Jan 8;47(D1):D1018-D1027
pubmed: 30476213
Dev Med Child Neurol. 2022 Dec;64(12):1470-1476
pubmed: 35441707

Auteurs

Yana A Wilson (YA)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Hayley Smithers-Sheedy (H)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Katarina Ostojic (K)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Emma Waight (E)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Michael C Kruer (MC)

Pediatric Movement Disorders Program, Barrow Neurological Institute, Phoenix, Arizona, USA.
Departments of Child Health, Neurology, Cellular & Molecular Medicine and Program in Genetics, University of Arizona College of Medicine, Phoenix, Arizona, USA.

Michael C Fahey (MC)

Department of Paediatrics, Monash University, Melbourne, VIC, Australia.

Gareth Baynam (G)

Western Australian Register of Developmental Anomalies King Edward Memorial Hospital, Perth, WA, Australia.
Faculty of Health and Medical Sciences, Division of Paediatrics, University of Western Australia, Perth, WA, Australia.
Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia.
Telethon Kids Institute, University of Western Australia, WA, Australia.
Spatial Sciences, Department of Science and Engineering, Curtin University, WA, Australia.

Jozef Gécz (J)

Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia.
Adelaide Medical School, The University of Adelaide, SA, Australia.
South Australian Health and Medical Research Institute, Adelaide, SA, Australia.

Nadia Badawi (N)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Grace Centre for Newborn Intensive Care, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Sarah McIntyre (S)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Cerebral Palsy Alliance Research Institute, Specialty of Child & Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Telethon Kids Institute, University of Western Australia, WA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH